Internal Medicine · Mansfield, PA
NPI
1962415067
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
40 W Wellsboro St, Mansfield Laurel Health Center
Mansfield, PA, 16933
Phone (570) 662-2002
Groups this clinician bills Medicare through
Medicare paid, 2024
$31K
547 services
Medicare patients, 2024
150
Average age 74
Drug cost, 2024
$2.6M
17,145 prescriptions
Company payments, 2025
$1,519
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by George R Dy was code 99233 (hospital e&m - subsequent), 153 times for 52 patients. In total George R Dy billed 547 services in 19 codes, and Medicare paid $31K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 153 | 52 | $89.48 | $14K |
| 83036 Blood Count | Office | 90 | 56 | $9.52 | $857 |
| 82962 Clinical Chemistry | Office | 76 | 50 | $3.21 | $244 |
| 99232 Hospital E&M - Subsequent | Facility | 66 | 38 | $59.45 | $3,924 |
| 99239 Hospital Discharge Management | Facility | 47 | 30 | $86.13 | $4,048 |
| 81002 Clinical Chemistry | Office | 23 | 19 | $3.41 | $78.43 |
| 99223 Hospital E&M - Initial | Facility | 20 | 18 | $117.91 | $2,358 |
| 93005 Electrocardiogram | Office | 20 | 17 | $4.13 | $82.59 |
| 99291 Critical Care E&M | Facility | 14 | 12 | $161.02 | $2,254 |
By year: 2022 $87K for 818 services; 2023 $67K for 675 services; 2024 $31K for 547 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 90 | 56 | $9.52 | $857 |
| 82962 Clinical Chemistry | 76 | 50 | $3.21 | $244 |
| 81002 Clinical Chemistry | 23 | 19 | $3.41 | $78.43 |
Medicare prescription drug claims, 2024
In 2024, the drug George R Dy prescribed most often to Medicare patients was Allopurinol, with 957 prescriptions and refills. In total George R Dy wrote 17,145 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Allopurinol Generic | 957 | 2,470 | 265 | $9,892 |
| Atorvastatin Calcium Generic | 705 | 1,701 | 177 | $8,872 |
| Losartan Potassium Generic | 701 | 1,719 | 192 | $10K |
| Famotidine Generic | 553 | 1,266 | 148 | $10K |
| Rosuvastatin Calcium Generic | 537 | 1,404 | 159 | $9,385 |
| Amlodipine Besylate Generic | 472 | 1,185 | 126 | $3,627 |
| Levothyroxine Sodium Generic | 345 | 771 | 74 | $2,744 |
| Metoprolol Succinate Generic | 321 | 779 | 85 | $5,510 |
| Eliquis Apixaban | 300 | 476 | 52 | $242K |
| Tamsulosin Hcl Generic | 277 | 716 | 73 | $6,648 |
| Lisinopril Generic | 262 | 637 | 68 | $2,550 |
| Metformin Hcl Generic | 259 | 656 | 74 | $2,091 |
| Gabapentin Generic | 249 | 490 | 62 | $3,834 |
| Metoprolol Tartrate Generic | 222 | 411 | 47 | $2,024 |
| Simvastatin Generic | 221 | 493 | 44 | $2,093 |
Brand drugs: 3,007 claims; generic drugs: 14,026 claims; opioid claims: 246.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid George R Dy $1,519 ($1,519 in general payments such as food, travel and fees) from 19 companies. The largest payer was Novo Nordisk Inc with $200.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 12 | $200 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $200 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $170 |
| Amgen Inc. AMGN | 9 | $144 |
| Lilly USA, LLC LLY | 6 | $104 |
| Abbott Laboratories ABT | 5 | $93.73 |
| Dexcom, Inc. DXCM | 4 | $77.04 |
| Merck Sharp & Dohme LLC MRK | 4 | $71.7 |
| Abbvie Inc. ABBV | 3 | $61.98 |
| Exact Sciences Corporation EXAS | 3 | $60.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.